
1. zhonghua shi yan lin chuang bing du xue za zhi. 2002 dec;16(4):395-7.

[observation therapeutic effect lamivudin chronic hepatitis b].

[article chinese]

wen x(1), li x, xie h, chen n, zeng w, ru h, cui x, tang z.

author information: 
(1)the fifth affiliated hospital guangxi medical college, liuzhou 545001,
china.

objective: observe therapeutic effect lamivudine controlling
hepatitis b virus dna replication.
methods: liver disease patients divided two groups, treated
group (n=64) given lamivudine 100 mg day one year was
additionally given liver protection drugs according liver function,
while control group (n=30) given common liver protection drugs. blood
routine test, liver function viral markers detected defined
times.
results: results showed one year treatment chronic hepatitis b 
with lamivudine, recovery rate alt 90.7%, negative conversion rate
of hbv dna 73.1% showing significant difference compared the
control group (p<0.05). negative seroconversion rate hbeag 50%,
hbeag/anti hbe changing rate 38.2%, significant different as
compared control group (p<0.05). percentage disease relapse 
second elevation alt 3.1% therapeutic group significantly
different control group (p<0.05). two cases severe
hepatitis treated group alive.
conclusions: lamivudine could effectively control hbv dna replication, making alt
normal, also could decrease relapse rate chronic hepatitis b raise 
the survival rate patients liver disease.


pmid: 12665918  [indexed medline]

